| Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review FJ Bath‐Hextall, AJ Birnie, JC Ravenscroft, HC Williams British Journal of Dermatology 163 (1), 12-26, 2010 | 295 | 2010 |
| Translating Patient‐Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor‐based methods CR Charman, AJ Venn, JC Ravenscroft, HC Williams British Journal of Dermatology 169 (6), 1326-1332, 2013 | 265 | 2013 |
| Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial HC Williams, F Wojnarowska, G Kirtschig, J Mason, TR Godec, E Schmidt, ... The Lancet 389 (10079), 1630-1638, 2017 | 204 | 2017 |
| Widespread insecticide resistance in head lice to the over‐the‐counter pediculocides in England, and the emergence of carbaryl resistance AMR Downs, KA Stafford, LP Hunt, JC Ravenscroft, GC Coles British Journal of Dermatology 146 (1), 88-93, 2002 | 164 | 2002 |
| Interventions to reduce Staphylococcus aureus in the management of atopic eczema AJ Birnie, FJ Bath‐Hextall, JC Ravenscroft, HC Williams Cochrane Database of Systematic Reviews, 2008 | 157 | 2008 |
| Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus JC Ravenscroft, M Suri, GI Rice, M Szynkiewicz, YJ Crow American Journal of Medical Genetics Part A 155 (1), 235-237, 2011 | 120 | 2011 |
| The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the … JM Batchelor, MJ Ridd, T Clarke, A Ahmed, M Cox, S Crowe, M Howard, ... British Journal of Dermatology 168 (3), 577-582, 2013 | 118 | 2013 |
| Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials V Eleftheriadou, KS Thomas, ME Whitton, JM Batchelor, JC Ravenscroft British Journal of Dermatology 167 (4), 804-814, 2012 | 97 | 2012 |
| Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey E Wedgeworth, M Glover, AD Irvine, I Neri, E Baselga, TH Clayton, ... British Journal of Dermatology 174 (3), 594-601, 2016 | 95 | 2016 |
| Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership V Eleftheriadou, ME Whitton, DJ Gawkrodger, J Batchelor, J Corne, ... British Journal of Dermatology 164 (3), 530-536, 2011 | 86 | 2011 |
| Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK JC Ravenscroft, A Layton, M Barnham Clinical and experimental dermatology 25 (4), 327-330, 2000 | 79 | 2000 |
| Short‐term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema JC Ravenscroft, AM Layton, EA Eady, MS Murtagh, P Coates, M Walker, ... British Journal of Dermatology 148 (5), 1010-1017, 2003 | 75 | 2003 |
| Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines L Solman, M Glover, PE Beattie, H Buckley, S Clark, JE Gach, A Giardini, ... British Journal of Dermatology 179 (3), 582-589, 2018 | 74 | 2018 |
| Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study KS Thomas, AD Ormerod, FE Craig, N Greenlaw, J Norrie, E Mitchell, ... Journal of the American Academy of Dermatology 75 (5), 940-949, 2016 | 68 | 2016 |
| Genotype–phenotype correlation in a large English cohort of patients with autosomal recessive ichthyosis JK Simpson, M Martinez‐Queipo, A Onoufriadis, S Tso, E Glass, L Liu, ... British Journal of Dermatology 182 (3), 729-737, 2020 | 64 | 2020 |
| Interventions to reduce Staphylococcus aureus in the management of eczema SMC George, S Karanovic, DA Harrison, A Rani, AJ Birnie, ... Cochrane Database of Systematic Reviews, 2019 | 62 | 2019 |
| A novel NEMO gene mutation causing osteopetrosis, lymphoedema, hypohidrotic ectodermal dysplasia and immunodeficiency (OL-HED-ID) CML Roberts, JE Angus, IH Leach, EM McDermott, DA Walker, ... European journal of pediatrics 169, 1403-1407, 2010 | 62 | 2010 |
| British Association of Dermatologists guidelines for the management of people with vitiligo 2021 V Eleftheriadou, R Atkar, J Batchelor, B McDonald, L Novakovic, JV Patel, ... British Journal of Dermatology 186 (1), 18-29, 2022 | 60 | 2022 |
| Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic‐resistant propionibacteria in patients with acne P Coates, S Vyakrnam, JC Ravenscroft, GI Stables, WJ Cunliffe, ... British Journal of Dermatology 153 (6), 1126-1136, 2005 | 48 | 2005 |
| Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home … V Eleftheriadou, K Thomas, J Ravenscroft, M Whitton, J Batchelor, ... Trials 15, 1-12, 2014 | 44 | 2014 |
